Back
Viking Therapeutics Stock Price Chart
Sponsored
VKTX
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
82
VKTX
Viking Therapeutics
Last Price:
70.50
Seasonality Move:
18.2%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight buying pressure.
Viking Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.44 | Buy |
20-day SMA: | 61.93 | Buy |
50-day SMA: | 58.95 | Buy |
200-day SMA: | 52.78 | Buy |
8-day EMA: | 65.44 | Buy |
20-day EMA: | 62.64 | Buy |
50-day EMA: | 60.33 | Buy |
200-day EMA: | 51.47 | Buy |
Viking Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.24 | Buy |
Relative Strength Index (14 RSI): | 64.38 | Buy |
Chaikin Money Flow: | 348198 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.77 - 66.81) | Buy |
Bollinger Bands (100): | (51.91 - 68.49) | Buy |
Viking Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 70.54 while VKTX 8-day simple moving average is 65.44, which is a Buy signal.
- The stock price of VKTX is 70.54 while Viking Therapeutics 20-day SMA is 61.93, which makes it a Buy.
- Viking Therapeutics 50-day simple moving average is 58.95 while VKTX share price is 70.54, making it a Buy technically.
- VKTX stock price is 70.54 and Viking Therapeutics 200-day simple moving average is 52.78, creating a Buy signal.
VKTX Technical Analysis vs Fundamental Analysis
Buy
82
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a Buy
The current Viking Therapeutics [VKTX] share price is $70.54. The Score for VKTX is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
Viking Therapeutics Stock Info
Market Cap:
7.82B
Price in USD:
70.54
Share Volume:
6.38M
Viking Therapeutics 52-Week Range
52-Week High:
99.41
52-Week Low:
8.28
Buy
82
Viking Therapeutics (VKTX)
is a Buy
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?
The Viking Therapeutics stock price is 70.54 USD today. -
Will VKTX stock go up or go down?
Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Viking Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is not overvalued.
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 70.54 while VKTX 8-day exponential moving average is 65.44, which is a Buy signal.
- The stock price of VKTX is 70.54 while Viking Therapeutics 20-day EMA is 62.64, which makes it a Buy.
- Viking Therapeutics 50-day exponential moving average is 60.33 while VKTX share price is 70.54, making it a Buy technically.
- VKTX stock price is 70.54 and Viking Therapeutics 200-day simple moving average is 51.47, creating a Buy signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
- VKTX Moving Average Covergence Divergence (MACD) indicator is 2.24, suggesting Viking Therapeutics is a Buy
- Viking Therapeutics Relative Strength Index (RSI) is 64.38, which suggest Viking Therapeutics is overbought
- The Bollinger Bands (25) for Viking Therapeutics is (57.77 - 66.81), which suggest Viking Therapeutics is a Buy
- The Bollinger Bands (100) for Viking Therapeutics is (51.91 - 68.49), which suggest Viking Therapeutics is a Buy
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.